These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2780 related items for PubMed ID: 17854731

  • 1. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS, Klein SJ, Candelas AR, O'Connell DA, Rothman JR, Feldman IS, Tsui DS, Cotroneo RA, Flanigan CA.
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [Abstract] [Full Text] [Related]

  • 2. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
    Lazarus JV, Shete PB, Eramova I, Merkinaite S, Matic S.
    Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
    [Abstract] [Full Text] [Related]

  • 3. Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003.
    Emmanuelli J, Desenclos JC.
    Addiction; 2005 Nov; 100(11):1690-700. PubMed ID: 16277629
    [Abstract] [Full Text] [Related]

  • 4. The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settings.
    Islam M, Wodak A, Conigrave KM.
    Int J Drug Policy; 2008 Dec; 19(6):436-41. PubMed ID: 17766100
    [Abstract] [Full Text] [Related]

  • 5. The role of policy in community pharmacies' response to injection-drug use: results of a nationwide Canadian survey.
    Myers T, Cockerill R, Millson M, Rankin J, Worthington C.
    AIDS Public Policy J; 1996 Dec; 11(2):78-88. PubMed ID: 10915241
    [Abstract] [Full Text] [Related]

  • 6. Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan: delivering prevention services where most needed.
    Emmanuel F, Fatima M.
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S59-64. PubMed ID: 18281206
    [Abstract] [Full Text] [Related]

  • 7. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS, Brajachand N, Singh HL, Singh YM.
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.
    Rhodes T, Platt L, Judd A, Mikhailova LA, Sarang A, Wallis N, Alpatova T, Hickman M, Parry JV.
    Int J STD AIDS; 2005 Nov; 16(11):749-54. PubMed ID: 16303071
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study.
    Rhodes T, Platt L, Maximova S, Koshkina E, Latishevskaya N, Hickman M, Renton A, Bobrova N, McDonald T, Parry JV.
    Addiction; 2006 Feb; 101(2):252-66. PubMed ID: 16445554
    [Abstract] [Full Text] [Related]

  • 16. Everybody's got it, but...: situational and strategic participation in normalized HCV discourse among injection drug users in Edmonton, Canada.
    Wozniak L, Prakash M, Taylor M, Wild TC.
    Int J Drug Policy; 2007 Oct; 18(5):388-96. PubMed ID: 17854727
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 139.